{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:10:30Z","timestamp":1785553830367,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005678","name":"Jose Carreras Foundation for the fight against leukemia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["866548"],"award-info":[{"award-number":["866548"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["442788847"],"award-info":[{"award-number":["442788847"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["04R\/2019"],"award-info":[{"award-number":["04R\/2019"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019718","name":"Iten-Kohaut Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neo.2026.101308","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:05:04Z","timestamp":1776503104000},"page":"101308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model"],"prefix":"10.1016","volume":"77","author":[{"given":"Pia","family":"Radszuweit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Fitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-2855","authenticated-orcid":false,"given":"Sarah","family":"Bruestl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1488-9096","authenticated-orcid":false,"given":"Thomas","family":"Hentrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulya","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gonz\u00e1lez-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2509-860X","authenticated-orcid":false,"given":"Saskia","family":"Rudat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Marschalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Erkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7115-3560","authenticated-orcid":false,"given":"Hildegard","family":"Keppeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Schairer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Luib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0211-2343","authenticated-orcid":false,"given":"Markus","family":"Mezger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5365","authenticated-orcid":false,"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9242-2096","authenticated-orcid":false,"given":"Julia","family":"Schulze-Hentrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Schneidawind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-8980","authenticated-orcid":false,"given":"Corina","family":"Schneidawind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neo.2026.101308_bib0001","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of Haematolymphoid tumours: lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.neo.2026.101308_bib0002","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.neo.2026.101308_bib0003","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.neo.2026.101308_bib0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.neo.2026.101308_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0092-8674(03)00816-X","article-title":"Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression","volume":"115","author":"Hsieh","year":"2003","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.neo.2026.101308_bib0006","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1158\/0008-5472.CAN-06-2369","article-title":"Interaction of MLL amino terminal sequences with menin is required for transformation","volume":"67","author":"Caslini","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.neo.2026.101308_bib0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","article-title":"Menin critically links MLL proteins with LEDGF on cancer-associated target genes","volume":"14","author":"Yokoyama","year":"2008","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.neo.2026.101308_bib0008","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1128\/MCB.21.10.3589-3597.2001","article-title":"Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells","volume":"21","author":"Fair","year":"2001","journal-title":"Mol. Cell Biol"},{"issue":"2","key":"10.1016\/j.neo.2026.101308_bib0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jmb.2010.05.005","article-title":"Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription","volume":"400","author":"Chang","year":"2010","journal-title":"J. Mol. Biol"},{"issue":"22","key":"10.1016\/j.neo.2026.101308_bib0010","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.91.22.10610","article-title":"AT-hook\" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene","volume":"91","author":"Zeleznik-Le","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"10.1016\/j.neo.2026.101308_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2020.194547","article-title":"The reciprocal world of MLL fusions: a personal view","volume":"1863","author":"Marschalek","year":"2020","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech"},{"issue":"42","key":"10.1016\/j.neo.2026.101308_bib0012","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1038\/s41388-021-02001-2","article-title":"The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11)","volume":"40","author":"Wilhelm","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.neo.2026.101308_bib0013","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/bjh.12250","article-title":"Brazilian collaborative study group of infant acute L. The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia","volume":"161","author":"Emerenciano","year":"2013","journal-title":"Br J. Haematol"},{"issue":"7","key":"10.1016\/j.neo.2026.101308_bib0014","doi-asserted-by":"crossref","first-page":"601","DOI":"10.31083\/ph.2013.6514","article-title":"An alternative splice process renders the MLL protein either into a transcriptional activator or repressor","volume":"68","author":"Rossler","year":"2013","journal-title":"Pharmazie"},{"issue":"46","key":"10.1016\/j.neo.2026.101308_bib0015","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1038\/s41388-019-0937-9","article-title":"Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR\/Cas9","volume":"38","author":"Secker","year":"2019","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.neo.2026.101308_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312760","article-title":"Only infant MLL-rearranged leukemia is susceptible to an inhibition of polo-like Kinase 1 (PLK-1) by Volasertib","volume":"25","author":"Fischer","year":"2024","journal-title":"Int. J. Mol. Sci"},{"issue":"3","key":"10.1016\/j.neo.2026.101308_bib0017","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00428-023-03516-7","article-title":"Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer's ring in adults","volume":"482","author":"Streich","year":"2023","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.neo.2026.101308_bib0018","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood-2014-03-563304","article-title":"Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia","volume":"125","author":"Aoki","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.neo.2026.101308_bib0019","first-page":"1261","article-title":"Interleukin-3 receptor \u03b1 chain (CD123) is widely expressed in hematologic malignancies","volume":"86","author":"Mu\u00f1oz","year":"2001","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.neo.2026.101308_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.neo.2026.101308_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8522","article-title":"M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism","volume":"9","author":"Weinhauser","year":"2023","journal-title":"Sci. Adv"},{"issue":"6","key":"10.1016\/j.neo.2026.101308_bib0022","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/leu.2011.36","article-title":"CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression","volume":"25","author":"Saito","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.neo.2026.101308_bib0023","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2643-3230.BCD-20-0011","article-title":"Cell fate decisions: the role of transcription factors in early B-cell development and leukemia","volume":"1","author":"Fischer","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1016\/j.neo.2026.101308_bib0024","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1038\/s41467-024-53399-8","article-title":"MLL oncoprotein levels influence leukemia lineage identities","volume":"15","author":"Janssens","year":"2024","journal-title":"Nat. Commun"},{"issue":"1","key":"10.1016\/j.neo.2026.101308_bib0025","first-page":"523","article-title":"Microinjection of transforming ras protein induces c-fos expression","volume":"7","author":"Stacey","year":"1987","journal-title":"Mol. Cell Biol"},{"issue":"13","key":"10.1016\/j.neo.2026.101308_bib0026","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1073\/pnas.91.13.6030","article-title":"Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases","volume":"91","author":"Westwick","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"6","key":"10.1016\/j.neo.2026.101308_bib0027","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3324\/haematol.2012.067983","article-title":"Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants","volume":"98","author":"Driessen","year":"2013","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.neo.2026.101308_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/cells13141221","article-title":"Roychoudhury S. KRAS mutation subtypes and their association with other driver mutations in oncogenic pathways","volume":"13","author":"Mondal","year":"2024","journal-title":"Cells"},{"issue":"5\u20136","key":"10.1016\/j.neo.2026.101308_bib0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10428199809057558","article-title":"Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis","volume":"30","author":"Escribano","year":"1998","journal-title":"Leukemia. Lymphoma"},{"issue":"19","key":"10.1016\/j.neo.2026.101308_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910814","article-title":"ZNF521 Enhances MLL-AF9-dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape","volume":"22","author":"Chiarella","year":"2021","journal-title":"Int. J. Mol. Sci"},{"issue":"5","key":"10.1016\/j.neo.2026.101308_bib0031","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cell.2005.09.023","article-title":"A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C\/EBPalpha regulates human granulopoiesis","volume":"123","author":"Fazi","year":"2005","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.neo.2026.101308_bib0032","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2012-07-442004","article-title":"PBX3 is an important cofactor of HOXA9 in leukemogenesis","volume":"121","author":"Li","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.neo.2026.101308_bib0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exphem.2017.06.001","article-title":"TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia","volume":"53","author":"Sanda","year":"2017","journal-title":"Exp. Hematol"},{"issue":"5","key":"10.1016\/j.neo.2026.101308_bib0034","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41375-019-0656-9","article-title":"RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1","volume":"34","author":"Elcheva","year":"2020","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.neo.2026.101308_bib0035","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1182\/blood-2011-06-359182","article-title":"High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients","volume":"118","author":"Noordermeer","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.neo.2026.101308_bib0036","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/0008-5472.CAN-14-3625","article-title":"SOCS2 Controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias","volume":"75","author":"Vitali","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2026.101308_bib0037","article-title":"Expression of the Cavin Family in childhood leukemia and its implications in subtype diagnosis and prognosis evaluation","volume":"10","author":"Yang","year":"2022","journal-title":"Front. Pediatric"},{"key":"10.1016\/j.neo.2026.101308_bib0038","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3389\/fonc.2019.01567","article-title":"THBS1 Is a novel serum prognostic factors of acute myeloid leukemia","volume":"9","author":"Zhu","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.neo.2026.101308_bib0039","first-page":"4127","article-title":"The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?","volume":"11","author":"Ramirez-Cosmes","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"1","key":"10.1016\/j.neo.2026.101308_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yexcr.2019.03.009","article-title":"High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer","volume":"378","author":"Li","year":"2019","journal-title":"Exp. Cell Res"},{"issue":"Pt 1","key":"10.1016\/j.neo.2026.101308_bib0041","article-title":"Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer","volume":"274","author":"Sengupta","year":"2024","journal-title":"Int. J. Biol. Macromol"},{"issue":"11","key":"10.1016\/j.neo.2026.101308_bib0042","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.neo.2026.101308_bib0043","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/bloodadvances.2017013748","article-title":"Leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing","volume":"2","author":"Schneidawind","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.neo.2026.101308_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123297","article-title":"M2 macrophages secrete CCL20 to regulate iron metabolism and promote daunorubicin resistance in AML cells","volume":"361","author":"Chen","year":"2025","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.neo.2026.101308_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136644","article-title":"Use of genome engineering to create patient specific MLL translocations in primary Human hematopoietic stem and progenitor cells","volume":"10","author":"Breese","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neo.2026.101308_bib0046","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.leukres.2010.08.011","article-title":"t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL","volume":"35","author":"Kumar","year":"2011","journal-title":"Leuk Res"},{"issue":"21","key":"10.1016\/j.neo.2026.101308_bib0047","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.4161\/cc.7.21.6951","article-title":"Transforming human blood stem and progenitor cells: a new way forward in leukemia modeling","volume":"7","author":"Mulloy","year":"2008","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.neo.2026.101308_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061487","article-title":"Only hematopoietic stem and progenitor cells from cord blood are susceptible to malignant transformation by MLL-AF4 translocations","volume":"12","author":"Secker","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.neo.2026.101308_bib0049","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/s41467-021-27270-z","article-title":"A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program","volume":"12","author":"Rice","year":"2021","journal-title":"Nat. Commun"},{"issue":"3","key":"10.1016\/j.neo.2026.101308_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0044-1786557","article-title":"CRISPR\/Cas9-mediated KMT2A-rearrangements for the development of leukaemia mouse models","volume":"236","author":"Benz","year":"2024","journal-title":"Klin. Padiatr"},{"issue":"5824","key":"10.1016\/j.neo.2026.101308_bib0051","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barabe","year":"2007","journal-title":"Science"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:54:47Z","timestamp":1779000887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S1476558626000370"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101308","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101308"}}